The FDA is expected to make its decision on Priovant's application for brepocitinib in the third quarter. The company's rare ...

But it has done little to resolve the strategic incoherence at the heart of the U.S.-Israeli campaign that neither government has been willing to acknowledge publicly: the two partners have been ...

In-house software built in March with open-source components may include malware placed there by criminals. This isn’t a ...

Compare Brevo, Moosend, GetResponse & AWeber for nonprofit fundraising. Nigerian pricing, donation integration & honest pros/cons. Pay-per-email vs subscriber pricing analysed.